Detalhe da pesquisa
1.
Targeting of Aberrant αvß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Mol Ther
; 25(1): 259-273, 2017 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129120
2.
In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.
J Virol
; 83(13): 6416-28, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19369326